shutterstock_2183917051_t-schneider
T. Schneider / Shutterstock.com
12 October 2023FeaturesAmericasMary Prendergast, Mark Whitaker and Nicole Ang

Is the ITC the right venue for trade secrets theft?

Imagine this scenario: you suspect that an employee has walked out with your trade secrets or that a development partner has decided to make their own product using your IP. It seems increasingly likely you’ll need to file a lawsuit to get your trade secrets back or prevent your competitor from using them.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
17 January 2023   With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.
Biotechnology
27 January 2022   The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.

More on this story

Americas
17 January 2023   With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.
Biotechnology
27 January 2022   The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.

More on this story

Americas
17 January 2023   With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.
Biotechnology
27 January 2022   The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.